Abstract
The lysosomal storage diseases (LDSs) are a heterogeneous group of inherited genetic disorders caused by defects of lysosomal proteins. The accumulation of undigested substrates from different catabolic pathways leads to cellular dysfunction. LSDs generally presents during early childhood and have a devastating impact on the families and on public health. Over the years, approaches for treatment of some LSDs have been developed with different strategies. Increasing availability of treatments of these diseases has accelerated the development of new methods and techniques for rapid diagnosis in patients with clinical indication.
The use of dried blood spot (DBS) test has been proposed as a first tier test to identify patients with Gaucher, Pompe, and Fabry diseases. DBS usage is advantageous for the purpose of screening as it is non-invasive, sensitive, has low-cost and fast turnaround time compared to measurements in leucocyte and/or fibroblast culture. This chapter focuses on the activity measurement of three lysosomal enzymes (α-glucosidase, β-glucosidase, and α galactosidase) in DBS samples by using fluorescent substrates and by the LC-MS/MS (liquid chromatography-mass spectrometry) method. All steps of the methods, from preparation of the solutions to calculation of the enzyme activity, will be explained in detail.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pastores GM (2010) Lysosomal storage disorders, principles and practice. World Scientific Publishing Co, Singapore
Matern D, Gavrilov D, Oglesbee D, Raymond K, Rinaldo P, Tortorelli S (2015) Newborn screening for lysosomal storage disorders. Semin Perinatol 39:206–216
Kingma SDK, Bodamer OA, Wijburg FA (2015) Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Best Pract Res Clin Endocrinol Metab 29:145–157
Lukacs Z, Hartung R, Beck M, Keil A, Mengel E (2007) Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patients. J Inherit Metab Dis 30:614
Lukacs Z, Cobos PN, Mengel E, Hartung R, Beck M, Deschauer M, Keil A, Santer R (2010) Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes—possibility for newborn screening. J Inherit Metab Dis 33:43–50
Chamoles NA, Blanco M, Gaggioli D (2001) Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta 308:195–196
de Jesus VR, Zhang XK, Keutzer C, Bodamer OA, Mühl A, Orsini JJ, Caggana M, Vogt FV, Hannon WH (2009) Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem 55(1):158–164
Reusera AJ, Verheijena FW, Balib D, van Diggelena OP, Germain DP, Hwud WL, Lukacs Z, Mühlf A, Olivovag P, Piraudh M, Wuytsi B, Zhang K, Keutzerg J (2011) The use of dried blood spot samples in the diagnosis of lysosomal storage disorders — Current status and perspectives. Mol Genet Metab 104:144–148
Shigeto S, Katafuchi T, Okada Y, Nakamura K, Endo F, Okuyama T, Takeuchi H, Kroos MA, Verheijen FW, Reusera AJ (2011) Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots. Mol Genet Metab 103:12–17
Oemardien LF, Boer AM, Ruijter GJ, van der Ploeg AT, de Klerk JB, Reuser AJ, Verheijen FW (2011) Hemoglobin precipitation greatly improves 4-methylumbelliferonebased diagnostic assays for lysosomal storage diseases in dried blood spots. Mol Genet Metab 102:44–48
Sözmen EY (2012) Letter to Editor. Sample blank subtraction outreachs Hemoglobin interferences in flurorometric methods for DBS. Mol Genet Metab 105(3):530
Zhang H, Kallwass H, Young SP, Carr C, Dai J, Kishnani PS, Millington DS, Keutzer J, Chen YT, Bali D (2006) Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med 8(5):302–306
Orsini JJ, Martin MM, Showers AL, Bodamer OA, Zhang XK, Gelb MH, Caggana M (2012) Lysosomal storage disorder 4 + 1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disorders. Clin Chim Acta 413:1270–1273
La Marca G, Casetta B, Malvagia S, Guerrini R, Zammarchi E (2009) New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass spectrometry. Anal Chem 81:6113–6121
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Sozmen, E.Y., Sezer, E.D. (2017). Methods for Determination of α-Glycosidase, β-Glycosidase, and α-Galactosidase Activities in Dried Blood Spot Samples. In: Öllinger, K., Appelqvist, H. (eds) Lysosomes. Methods in Molecular Biology, vol 1594. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6934-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6934-0_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6932-6
Online ISBN: 978-1-4939-6934-0
eBook Packages: Springer Protocols